AU2002250307A1 - Improving postsynaptic response by a combination of 4-minopyridine and agonist - Google Patents

Improving postsynaptic response by a combination of 4-minopyridine and agonist

Info

Publication number
AU2002250307A1
AU2002250307A1 AU2002250307A AU2002250307A AU2002250307A1 AU 2002250307 A1 AU2002250307 A1 AU 2002250307A1 AU 2002250307 A AU2002250307 A AU 2002250307A AU 2002250307 A AU2002250307 A AU 2002250307A AU 2002250307 A1 AU2002250307 A1 AU 2002250307A1
Authority
AU
Australia
Prior art keywords
minopyridine
agonist
improving
combination
postsynaptic response
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002250307A
Inventor
Daniel L. Alkon
Maurizio Grimaldi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU2002250307A1 publication Critical patent/AU2002250307A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002250307A 2001-03-14 2002-03-14 Improving postsynaptic response by a combination of 4-minopyridine and agonist Abandoned AU2002250307A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27546301P 2001-03-14 2001-03-14
US60/275,463 2001-03-14
PCT/US2002/007563 WO2002072025A2 (en) 2001-03-14 2002-03-14 Improving postsynaptic response by a combination of 4-minopyridine and agonist

Publications (1)

Publication Number Publication Date
AU2002250307A1 true AU2002250307A1 (en) 2002-09-24

Family

ID=23052390

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002250307A Abandoned AU2002250307A1 (en) 2001-03-14 2002-03-14 Improving postsynaptic response by a combination of 4-minopyridine and agonist

Country Status (2)

Country Link
AU (1) AU2002250307A1 (en)
WO (1) WO2002072025A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3348B1 (en) * 2009-08-11 2019-03-13 Acorda Therapeutics Inc Use of 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric impairment in patients with demyelinating and other nervous system conditions
US10793893B2 (en) 2011-06-30 2020-10-06 Serb Sa Methods of administering 3,4-diaminopyridine
US9617215B2 (en) 2012-05-17 2017-04-11 The University Of Chicago Use of fluorinated derivatives of 4-aminopyridine in therapeutics and medical imaging

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5794887A (en) * 1995-11-17 1998-08-18 Komerath; Narayanan M. Stagnation point vortex controller
US5952339A (en) * 1998-04-02 1999-09-14 Bencherif; Merouane Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release

Also Published As

Publication number Publication date
WO2002072025A3 (en) 2003-05-15
WO2002072025A2 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
AU2002363672A1 (en) Analysing events
AU2002360508A1 (en) Substituted hydroxyethylamines
AU2002341834A1 (en) Antagonists
AU2002367404A1 (en) Redox-switchable materials
AU2002249102A1 (en) Family 74 xyloglucanases
AU2002251024A1 (en) Substituted fluoroalcoxyphenylsulfonylurea
AU2002321215A1 (en) Substituted 4-aminocyclohexanols
AU2002318396A1 (en) Homocysteinylated transthyretin
AU2002337053A1 (en) Measuring transformer
AU2002307031A1 (en) Thrombospondin-2 and uses thereof
AU2002366271A1 (en) New herbicidal compounds and method
AU2002250307A1 (en) Improving postsynaptic response by a combination of 4-minopyridine and agonist
AU2002251543A1 (en) Novel atisane compound and use thereof
AU2994100A (en) Linked Bridge
AU2002248520A1 (en) Markless trigger
AU2002339298A1 (en) Plectrum
AU2002365149A1 (en) Receptors for hypersensitive response elicitors and uses thereof
AU2002356679A1 (en) Clusianon isomers and use thereof
AU2002321347A1 (en) Selecting an operational mode of a codec
AU2002321166A1 (en) Substituted 1-aryl-but-3-enylamine and 1-ary-but-2-enylamine compounds
AU2002237189A1 (en) New use of phencynonate hydrochloride
AU2002238356A1 (en) New use of phencynonate hydrochloride
AU2002354910A1 (en) Antifungal agents of sordarin derivatives
AUPR846601A0 (en) Bouillon alarm
AU2002241105A1 (en) Bridge

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase